Collaborators
Prof. Stefano Stefani, Montreal Neurological Institute, McGill University, Canada, Innovative discovery neurotechnology, 2012
Professor N. de Stefano, University of Siena
Dr Olga Ciccarelli, University College London, Institute of Neurology, Dept of Neuroinflammation
Dr Simon Schultz, Imperial College London, Department of Bioengineering
Professor Yi-ke Guo, Imperial College London, Computing Science
Profs. Heidi Johansen-Berg and S. Smith, FMRIB Centre, University of Oxford
Guest Lectures
Brain Plasticity and the Conundrum of Disability Progression in Multiple Sclerosis, Insights into MS disease mechanisms and novel therapeutic approaches, 2014 Neuroinflammation Symposium, Toronto, Canada, 2014
Molecular imaging in new medicine development, International Symposium on Drug Development Imaging Technology, Hanyang University, Seoul, Korea, 2013
Clinical imaging for new medicine development, Samsung Medical Centre, Seoul, Korea, 2013
Innovation challenges for clinical imaging in new drug development, Gil Medical Centre, Seoul, Korea, 2013
Beyond mere biomarkers: taking on the challenge of stratified medicine, MS Masterclass, Bristol, 2013
The Art of the Brain and understanding the Brain through Art, An Evening with Andrew Marr in Aid of the Stroke Unit, Charing Cross Hospital, London, 2013
So you want to develop a drug?, MRC Seminar Series, 2013
Imaging in UK Biobank, Annual Royal College of Radiologists/Wellcome Trust Research day, London, 2013
UK Biobank: the imaging enhancement and promise as a platform for dementia research, 2nd International Conference on the Standard Construction of Beijing Biobank of Clinical Resources, Beijing, China, 2013
The UK-Korea Academic Health Science Alliance Initiative, London Health Forum, London, 2013
Raising the Bar in MS, AIMS regional meeting, London, 2013
Dementia and the fragmentation of the self (read by Dr. Jan Winkowski), International Comparative Literature Annual Conference, Paris, 2013
Neurotechnology as a therapeutic modality, Tsinghua University, Beijing, China, 2013
Entering a new era of large scale, open imaging resources, Imaging Neurodegeneration and Neuroprotection in MS Symposium, London, 2013
Major problems in MS, ISMRM Educational Symposium: Multiple Sclerosis as a Whole-Brain Disease, UCL, London, 2013
Imaging technology development for the 3Rs, NC3Rs/ESP KTN Workshop, London, 2013
Opportunities for International Collaborative Healthcare Science, London Health Forum, Korean Healthcare IDI, London, 2013
Emerging evidence on brain atrophy as a measure of disease progression and treatment effect, Association of British Neurologists, Glasgow, 2013
OPTIMISE: a programme for stratified medicine in MS. Invited Speaker. One Mind for Research Annual Meeting, Johns Hopkins University, Baltimore, Maryland, 2013
Connectivity Studies in Large Populations: Towards Defining Disease Mechanisms and Risk, ISMRM Annual Meeting Educational Course, Salt Lake City, USA, 2013
From Science to Therapeutics: The Best Way Forward. Invited Lecture., A Gladstone Institute-DZNE Workshop, Neurodegeneration and inflammation, UCSF, USA, 2013
OPTIMISE: a UK Consortium for Stratified Medicine, UK MS Debating Society, 2013
A national effort for translational neuroscience and imaging. Showcasing British Neuroscience, Wellcome Trust, London, 2013
Industry-academic partnerships for rare disease medicine development, University College London, Great Ormond Street Hospital Rare Diseases Workshop, 2013
Industry-academic partnerships for rare disease medicine development, University College London, Great Ormond Street Hospital Rare Diseases Workshop, 2013
PET imaging of microglial activation with PET, National Institute of Neurological Disease, Tokyo, 2012
Microglial imaging in multiple sclerosis. Distinguished Professorial Lecture Series, Dept. Of Radiology, Case Western Reserve University, 2012
Alzheimer’s Disease and the fragmentation of the self. Neuroscience and Literature Symposium, Banbury Centre, Cold Spring Harbor, USA, 2012
Japan-UK collaborative science in multimodal brain imaging (Chair’s opening remarks). UK-Japan Multimodal Brain Imaging Symposium, Kavli Centre, UK, 2012
Achieving effective translation. Invited lecture, Next Generation Brain Imaging Technologies, Wellcome Trust, 2011
Extending the phenotype in association studies through imaging genomics. BHF Centre of Excellence Annual Symposium Lecture, Nuffield Department of Medicine, University of Oxford, 2011
Imaging activated microglia using PET, Brigham and Women’s Hospital, Harvard University, Boston USA, 2011
Brain imaging for population-based epidemiology. UK Biobank Launch Meeting, Wellcome Trust, London, 2011
Imaging genomics: from molecule to systems, Centre for Neurodegenerative Disease, VA Medical Centre, University of California, San Francisco, 2011
Advances in Multiple Sclerosis, Royal College of Physicians Advanced Medicine Course, London, 2011
Therapeutics development: changing the paradigm workshop. Invited lecture, British Pharmacological Society, QEII Conference Centre, London, 2010
Brain imaging for understanding the molecular bases of cognition. Killem Lecture, Montreal Neurological Institute, Montreal, 2010
Multimodal imaging for drug development. Invited Lecture and UK Lead, Japan- UK Science Workshop, British Embassy, Tokyo, 2010
Translation of new technologies towards the clinic, drug discovery and development in the 21st century. FRAME symposium, The Royal Society, London, 2009
Imaging for translational neuroscience drug development. Keynote speaker, Medical Imaging Workshop, Canadian Institutes of Health Research, Vancouver, 2009
Functional and molecular imaging for translational neuroscience. Plenary Lecture, Neuroscience Ireland Annual Meeting, Dublin, 2009
Imaging for translational medicine. Invited Speaker, Institute for Translational Medicine and Therapeutics 2009, International Symposium - ‘Global Approaches to Translational Research’, University of Pennsylvania, 2009
Imaging plasticity in the human brain. Feindel Lecture, Montreal Neurological Institute, Montreal, 2009